The transcriptional activity of hepatocyte nuclear factor 4 alpha is inhibited via phosphorylation by ERK1/2

PLoS One. 2017 Feb 14;12(2):e0172020. doi: 10.1371/journal.pone.0172020. eCollection 2017.

Abstract

Hepatocyte nuclear factor 4 alpha (HNF4α) nuclear receptor is a master regulator of hepatocyte development, nutrient transport and metabolism. HNF4α is regulated both at the transcriptional and post-transcriptional levels by different mechanisms. Several kinases (PKA, PKC, AMPK) were shown to phosphorylate and decrease the activity of HNF4α. Activation of the ERK1/2 signalling pathway, inducing proliferation and survival, inhibits the expression of HNF4α. However, based on our previous results we hypothesized that HNF4α is also regulated at the post-transcriptional level by ERK1/2. Here we show that ERK1/2 is capable of directly phosphorylating HNF4α in vitro at several phosphorylation sites including residues previously shown to be targeted by other kinases, as well. Furthermore, we also demonstrate that phosphorylation of HNF4α leads to a reduced trans-activational capacity of the nuclear receptor in luciferase reporter gene assay. We confirm the functional relevance of these findings by demonstrating with ChIP-qPCR experiments that 30-minute activation of ERK1/2 leads to reduced chromatin binding of HNF4α. Accordingly, we have observed decreasing but not disappearing binding of HNF4α to the target genes. In addition, 24-hour activation of the pathway further decreased HNF4α chromatin binding to specific loci in ChIP-qPCR experiments, which confirms the previous reports on the decreased expression of the HNF4a gene due to ERK1/2 activation. Our data suggest that the ERK1/2 pathway plays an important role in the regulation of HNF4α-dependent hepatic gene expression.

MeSH terms

  • Chromatin / genetics
  • Chromatin / metabolism
  • Enzyme Activation / physiology
  • HeLa Cells
  • Hep G2 Cells
  • Hepatocyte Nuclear Factor 4 / genetics
  • Hepatocyte Nuclear Factor 4 / metabolism*
  • Hepatocytes / cytology
  • Hepatocytes / metabolism*
  • Humans
  • MAP Kinase Signaling System / physiology*
  • Mitogen-Activated Protein Kinase 1 / genetics
  • Mitogen-Activated Protein Kinase 1 / metabolism*
  • Mitogen-Activated Protein Kinase 3 / genetics
  • Mitogen-Activated Protein Kinase 3 / metabolism*
  • Phosphorylation / physiology
  • Transcription, Genetic / physiology*

Substances

  • Chromatin
  • HNF4A protein, human
  • Hepatocyte Nuclear Factor 4
  • MAPK1 protein, human
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3

Grants and funding

The work was supported by grants from the MedinProt Program of the Hungarian Academy of Sciences (LB and TA). BLB is a Szodoray Fellow of the University of Debrecen, Medical Faculty, in which his research was funded by an Internal Research University Grant entitled, “Dissecting the genetic and epigenetic components of gene expression regulation in the context of 1000 genomes project”. This work was also supported by the Országos Tudományos Kutatási Alapprogramok (OTKA, Hungarian National Research Fund) through grants K100638, K104227, and NN 110115. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.